Cargando…

Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma

Purpose: This study was conducted in order to analyze the prognostic effects of epidermal growth factor receptor (EGFR) and CDKN2A alterations and determine the prognostic significance of EGFR and CDKN2A alterations on regulated genes in patients with glioblastoma (GBM) or lower grade glioma (LGG)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haiwei, Wang, Xinrui, Xu, Liangpu, Zhang, Ji, Cao, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093400/ https://www.ncbi.nlm.nih.gov/pubmed/33959491 http://dx.doi.org/10.3389/fonc.2021.551160

Ejemplares similares

Prognostic significance of age related genes in patients with lower grade glioma
por: Wang, Haiwei, et al.
Publicado: (2020)

Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer
por: Wang, Haiwei, et al.
Publicado: (2020)

CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma
por: Wang, Haiwei, et al.
Publicado: (2022)

CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma
por: Qiao, Juanli, et al.
Publicado: (2021)

A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma
por: Wang, Haiwei, et al.
Publicado: (2021)

RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma
por: Wang, Haiwei, et al.
Publicado: (2021)

Young men in spats
por: Wodehouse, P. G. 1881-1975 (Pelham Grenville)

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
por: Ma, Sirui, et al.
Publicado: (2020)

Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report
por: Jing, Wei, et al.
Publicado: (2020)

Co‐amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma
por: Wang, Haiwei, et al.
Publicado: (2022)

Detection of somatic copy number deletion of the CDKN2A gene by quantitative multiplex PCR for clinical practice
por: Tian, Yuan, et al.
Publicado: (2022)

Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis
por: Wu, Yaqi, et al.
Publicado: (2023)

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy
por: Grard, Marion, et al.
Publicado: (2021)

Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma
por: Wang, Haiwei, et al.
Publicado: (2021)

Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts
por: Wang, Haiwei, et al.
Publicado: (2022)

Experimental infection of Pacific oyster Crassostrea gigas spat by ostreid herpesvirus 1: demonstration of oyster spat susceptibility
por: Schikorski, David, et al.
Publicado: (2011)

Analysis of the transcriptomic features of microsatellite instability subtype colon cancer
por: Wang, Haiwei, et al.
Publicado: (2019)

CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner
por: Zhu, Zhen, et al.
Publicado: (2021)

Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets
por: Wang, Haiwei, et al.
Publicado: (2020)

Comprehensive evaluation of SPATS2 expression and its prognostic potential in liver cancer
por: Xing, Jin, et al.
Publicado: (2020)

Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
por: Huang, L. Eric
Publicado: (2022)

Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas
por: Kocakavuk, Emre, et al.
Publicado: (2023)

Clinical and Biological Significances of a Methyltransferase-Related Signature in Diffuse Glioma
por: Zhang, Ying, et al.
Publicado: (2020)

Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma
por: Zhuo, Shenghua, et al.
Publicado: (2020)

Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma
por: Zhou, Zunjie, et al.
Publicado: (2022)

CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition
por: Pinton, Giulia, et al.
Publicado: (2021)

SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma
por: Lin, Jing, et al.
Publicado: (2023)

Observations of the genomic landscape beyond 1p19q deletions and EGFR amplification in glioma
por: Paxton, Christian N., et al.
Publicado: (2015)

Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition
por: Pinton, Giulia, et al.
Publicado: (2022)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

Integrated analysis of the E2F transcription factors across cancer types
por: Wang, Haiwei, et al.
Publicado: (2020)

Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles
por: Zhang, Tan, et al.
Publicado: (2022)

Chromosome 1p36 candidate gene ZNF436 predicts the prognosis of neuroblastoma: a bioinformatic analysis
por: Wang, Haiwei, et al.
Publicado: (2023)

Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes
por: Feng, Jing, et al.
Publicado: (2022)

P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
por: Vij, Meenakshi, et al.
Publicado: (2023)

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification
por: Meedendorp, Arenda D., et al.
Publicado: (2018)

Nonnegative matrix factorization‐based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub‐consensuses of lung adenocarcinoma
por: Wang, Haiwei, et al.
Publicado: (2021)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis
por: Ortiz, Berenice, et al.
Publicado: (2014)

Wer zu spät reagiert, steht ohne Absicherung da
por: Schmidt-Kasparek, Uwe
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_11blhl3a2ljigbuf8tama8pl42